149 related articles for article (PubMed ID: 35566684)
1. Incidence, Treatment and Clinical Impact of Iron Deficiency in Chronic Heart Failure: A Longitudinal Analysis.
Miñana G; Lorenzo M; Ramirez de Arellano A; Wächter S; de la Espriella R; Sastre C; Mollar A; Núñez E; Bodí V; Sanchis J; Bayés-Genís A; Núñez J
J Clin Med; 2022 May; 11(9):. PubMed ID: 35566684
[TBL] [Abstract][Full Text] [Related]
2. Should we use ferritin in the diagnostic criteria of iron deficiency in heart failure patients?
Gentil JRS; Fabricio CG; Tanaka DM; Suen VMM; Volpe GJ; Marchini JS; Simões MV
Clin Nutr ESPEN; 2020 Oct; 39():119-123. PubMed ID: 32859304
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of transferrin saturation in heart failure patients.
Campodonico J; Nicoli F; Motta I; Migone De Amicis M; Bonomi A; Cappellini M; Agostoni P
Eur J Prev Cardiol; 2021 Dec; 28(15):1639-1646. PubMed ID: 33619543
[TBL] [Abstract][Full Text] [Related]
4. Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence.
Gonzalez-Costello J; Cainzos-Achirica M; Lupón J; Farré N; Moliner-Borja P; Enjuanes C; de Antonio M; Fuentes L; Díez-López C; Bayés-Genis A; Manito N; Pujol R; Comin-Colet J
Eur J Intern Med; 2020 Oct; 80():91-98. PubMed ID: 32439287
[TBL] [Abstract][Full Text] [Related]
5. Criteria for Iron Deficiency in Patients With Heart Failure.
Masini G; Graham FJ; Pellicori P; Cleland JGF; Cuthbert JJ; Kazmi S; Inciardi RM; Clark AL
J Am Coll Cardiol; 2022 Feb; 79(4):341-351. PubMed ID: 35086656
[TBL] [Abstract][Full Text] [Related]
6. Iron deficiency and risk of early readmission following a hospitalization for acute heart failure.
Núñez J; Comín-Colet J; Miñana G; Núñez E; Santas E; Mollar A; Valero E; García-Blas S; Cardells I; Bodí V; Chorro FJ; Sanchis J
Eur J Heart Fail; 2016 Jul; 18(7):798-802. PubMed ID: 27030541
[TBL] [Abstract][Full Text] [Related]
7. Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis.
Yeo TJ; Yeo PS; Ching-Chiew Wong R; Ong HY; Leong KT; Jaufeerally F; Sim D; Santhanakrishnan R; Lim SL; M Y Chan M; Chai P; Low AF; Ling LH; Ng TP; Richards AM; Lam CS
Eur J Heart Fail; 2014 Oct; 16(10):1125-32. PubMed ID: 25208495
[TBL] [Abstract][Full Text] [Related]
8. Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.
López-Vilella R; Lozano-Edo S; Arenas Martín P; Jover-Pastor P; Ezzitouny M; Sorolla Romero J; Calvo Asensio M; Martínez-Solé J; Guerrero Cervera B; Sánchez Martínez JC; Donoso Trenado V; Sánchez-Lázaro I; Martinez Dolz L; Almenar Bonet L
ESC Heart Fail; 2022 Feb; 9(1):133-145. PubMed ID: 34964300
[TBL] [Abstract][Full Text] [Related]
9. How to diagnose iron deficiency in chronic disease: A review of current methods and potential marker for the outcome.
Rohr M; Brandenburg V; Brunner-La Rocca HP
Eur J Med Res; 2023 Jan; 28(1):15. PubMed ID: 36617559
[TBL] [Abstract][Full Text] [Related]
10. Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype.
Fitzsimons S; Yeo TJ; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Poppe K; Lund M; Devlin G; Troughton R; Lam CSP; Richards AM; Doughty RN
ESC Heart Fail; 2021 Dec; 8(6):4572-4583. PubMed ID: 34592056
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum iron level and physical function in heart failure patients is lost by presence of diabetes.
Ohori K; Yano T; Katano S; Nagaoka R; Numazawa R; Yamano K; Fujisawa Y; Kouzu H; Nagano N; Fujito T; Nishikawa R; Ohwada W; Sato T; Furuhashi M
ESC Heart Fail; 2024 Feb; 11(1):513-523. PubMed ID: 38088258
[TBL] [Abstract][Full Text] [Related]
12. Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients.
Grote Beverborg N; Klip IT; Meijers WC; Voors AA; Vegter EL; van der Wal HH; Swinkels DW; van Pelt J; Mulder AB; Bulstra SK; Vellenga E; Mariani MA; de Boer RA; van Veldhuisen DJ; van der Meer P
Circ Heart Fail; 2018 Feb; 11(2):e004519. PubMed ID: 29382661
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of iron status in patients with heart failure.
Jankowska EA; Tkaczyszyn M; Drozd M; Ponikowski P
Eur Heart J Suppl; 2019 Dec; 21(Suppl M):M32-M35. PubMed ID: 31908613
[TBL] [Abstract][Full Text] [Related]
14. Iron deficiency and short-term adverse events in patients with decompensated heart failure.
Palau P; Llàcer P; Domínguez E; Tormo JP; Zakarne R; Mollar A; Martínez A; Miñana G; Santas E; Almenar L; Fácila L; De La Espriella R; Núñez E; Manzano L; Bayés-Genís A; Núñez J
Clin Res Cardiol; 2021 Aug; 110(8):1292-1298. PubMed ID: 33721056
[TBL] [Abstract][Full Text] [Related]
15. Iron deficiency in new onset heart failure: association with clinical factors and quality of life.
Cabrera CC; Ekström M; Tornvall P; Löfström U; Frisk C; Linde C; Hage C; Persson H; Eriksson MJ; Wallén H; Persson B; Lyngå P
ESC Heart Fail; 2024 May; ():. PubMed ID: 38803153
[TBL] [Abstract][Full Text] [Related]
16. Iron deficiency: Prevalence and relation to cardiovascular biomarkers in heart failure outpatients.
Schou M; Bosselmann H; Gaborit F; Iversen K; Goetze JP; Soletomas G; Rasmussen J; Kistorp C; Kober L; Gustafsson F; Tonder N
Int J Cardiol; 2015 Sep; 195():143-8. PubMed ID: 26043148
[TBL] [Abstract][Full Text] [Related]
17. High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality.
Sierpinski R; Josiak K; Suchocki T; Wojtas-Polc K; Mazur G; Butrym A; Rozentryt P; van der Meer P; Comin-Colet J; von Haehling S; Kosmala W; Przewlocka-Kosmala M; Banasiak W; Nowak J; Voors AA; Anker SD; Cleland JGF; Ponikowski P; Jankowska EA
Eur J Heart Fail; 2021 Jun; 23(6):919-932. PubMed ID: 33111457
[TBL] [Abstract][Full Text] [Related]
18. Applicability of new proposed criteria for iron deficiency in Japanese patients with heart failure.
Tada A; Nagai T; Koya T; Nakao M; Ishizaka S; Mizuguchi Y; Aoyagi H; Imagawa S; Tokuda Y; Takahashi M; Kato Y; Machida M; Matsutani K; Saito T; Anzai T;
ESC Heart Fail; 2023 Apr; 10(2):985-994. PubMed ID: 36495060
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency.
Ponikowski P; van Veldhuisen DJ; Comin-Colet J; Ertl G; Komajda M; Mareev V; McDonagh TA; Parkhomenko A; Tavazzi L; Levesque V; Mori C; Roubert B; Filippatos G; Ruschitzka F; Anker SD
ESC Heart Fail; 2014 Sep; 1(1):52-58. PubMed ID: 28834668
[TBL] [Abstract][Full Text] [Related]
20. Impact of iron deficiency on long-term clinical outcomes of hospitalized patients with heart failure.
Nakano H; Nagai T; Sundaram V; Nakai M; Nishimura K; Honda Y; Honda S; Iwakami N; Sugano Y; Asaumi Y; Aiba T; Noguchi T; Kusano K; Yokoyama H; Ogawa H; Yasuda S; Chikamori T; Anzai T;
Int J Cardiol; 2018 Jun; 261():114-118. PubMed ID: 29580659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
